Sol Global Investments

Heavenly Rx is a wellness company based in Toronto, Canada, focused on harnessing the benefits of CBD. The company is dedicated to creating products that enhance consumers' daily lives through the power of cannabinoids. Heavenly Rx aims to establish controlling ownership interests in a range of assets within the hemp and THC-free cannabinoid wellness sectors, reflecting its commitment to the growing demand for wellness solutions grounded in natural ingredients.

GreenLight Medicines is a biopharmaceutical company dedicated to researching and developing cannabinoid formulations to address various disease areas. The company specializes in creating plant-derived cannabinoid molecules from proprietary strains, supported by a robust intellectual property portfolio that includes unique blends of cannabinoids, advanced plant oil extraction processes, and innovative cannabis cultivation technologies. These developments enable medical practitioners to treat a range of conditions, including inflammatory diseases, cancer, and neurological disorders.

Verano Holdings is a vertically integrated multi-state cannabis operator in the United States, focused on enhancing communal wellness through responsible access to regulated cannabis products. The company operates two main segments: cultivation and retail. Its cultivation segment involves wholesale distribution, while the retail segment includes a network of dispensaries that operate under the brands Zen Leaf and MÜV. Verano's consumer brands encompass Encore, Avexia, MÜV, Savvy, and BITS, contributing to its diverse product offerings. The company's revenue primarily originates from its retail segment, reflecting its commitment to providing quality cannabis products to consumers across multiple states.